Benzer and OHM Pharmacy: The Pharmacy Answering for the Physician

Whistleblower Justice Network

In the Benzer and OHM Pharmacy case, Benzer agreed to pay $1,018,000 in a civil settlement over false Evzio prior authorization requests. The pharmacy admitted submitting clinical answers as though they came from prescribing physicians, signing some forms without permission and directing insurers’ questions back to itself. OHM later pleaded guilty in a separate criminal resolution. For someone who handled pharmacy prior authorizations, the revealing detail is the fax number: the business selling the drug made sure it would also answer the questions about approving it.

The civil case began with a whistleblower who had worked for Evzio’s manufacturer. Benzer Pharmacy Holding operated a specialty pharmacy in Tampa, Florida, and managed Benzer Pharmacy franchises. The admissions describe work done by employees called Patient Assistance Specialists, who completed and submitted authorization requests for Evzio, certain dermatological products and other drugs.

Why Evzio Approval Mattered

Evzio was an injectable naloxone product used in an opioid-overdose emergency. During the period covered by the agreement, it was the highest-priced naloxone product on the market. Insurers frequently required prior authorization before agreeing to cover it.

That requirement put the patient’s clinical information between the prescription and payment. Government insurers, including Medicare Part D plans, required information about the beneficiary before making the coverage decision. They often required that information to come directly from the prescribing physician’s office.

That put the pharmacy’s assistance staff in the middle. The prescriber supplied the order and clinical instructions. The pharmacy sought approval and submitted the claim. The insurer decided whether to pay. Benzer’s admissions show how the pharmacy crossed those roles: it supplied the clinical account and presented itself as the physician supplying it.

The agreement makes the financial purpose explicit. False clinical information helped secure approval and payment for the more expensive drug. The question on the form might concern an earlier treatment or a patient’s physical condition, but the answer determined whether the pharmacy could get paid for Evzio.

What the Authorization Form Concealed

Benzer’s admitted authorization practices changed who appeared to be speaking, who received follow-up questions and what the insurer was told about the patient. Those details worked together. Each field helped make the pharmacy’s submission look like a clinical account from somewhere else.

A Signature Without the Physician’s Permission

Patient Assistance Specialists completed Evzio authorization forms in place of prescribing physicians. In some instances, they signed without the physician’s authorization. Benzer then submitted the forms to insurers, including Medicare Part D plans, as if it were the physician.

The prescription and the authorization carried different information. A prescription named the drug the physician ordered. The authorization supplied the additional clinical answers the insurer wanted before agreeing to cover it. Benzer admitted putting its own staff in the physician’s place for that second exchange.

For an authorization employee, the important detail may be who supplied an answer or who directed a signature. We connect that account to the form the insurer received and the prescriber’s actual authorization. The person who recognizes a signature or remembers a request can explain how the submission acquired its apparent authority.

The Fax Number That Kept Questions Inside the Pharmacy

On dozens of requests, Benzer entered its own fax numbers in the space for the prescribing physician’s fax number. It admitted doing this so insurers would contact Benzer instead of the listed physician about the request.

That is a remarkably useful field to falsify. The form appeared to speak for the physician, while its contact information brought the insurer back to the pharmacy. We see the problem in that loop: the business seeking payment also controlled where questions about its clinical answers went.

A fax number looks like administrative detail until it explains who could answer for the patient. Knowing which office actually owned that number could make the difference between seeing an ordinary completed form and understanding how it worked.

A Patient History Written to Obtain Coverage

Benzer admitted submitting dozens of forms falsely stating that patients had tried and failed both Narcan and naloxone. It also falsely stated that patients had shaky hands or nasal problems. These were the reasons offered to secure approval and payment for Evzio.

Those answers concerned the patient’s treatment history and physical condition. The pharmacy stood to receive payment for the drug that the answers helped approve. An employee who knows where those statements originated may understand the transaction in a way the final form alone never reveals.

This is also where authorization work meets pharmacy diagnosis certifications. Both put clinical information into a coverage decision. The Benzer admissions go further into authorship: the pharmacy supplied false information while presenting the submission as the physician’s.

Benzer Admitted Knowing the Answers Affected Payment

The government’s civil claims covered Medicare billing tied to the authorization conduct from September 1, 2016 through March 29, 2019. Benzer admitted that government insurers, including Medicare Part D plans, approved false Evzio requests. Its admission about what it understood is particularly direct:

The Defendants understood that had the insurers known that the forms contained false information, they would not have authorized and paid for the prescriptions.

Benzer Pharmacy Holding civil settlement agreement, admitted facts, May 2024

That connects the false answer to the government payment, and the pharmacy’s knowledge to both. Taxpayers paid for prescriptions the pharmacy understood would not have been approved on truthful information.

Benzer also admitted failing to adequately oversee and train the staff handling authorization requests. The resolution reached that process through an integrity agreement with the Department of Health and Human Services Office of Inspector General. The Justice Department’s description of the agreement says Benzer had to implement measures to ensure that pharmaceutical claims complied with prior authorization requirements.

What OHM Admitted in the Criminal Resolution

OHM Pharmacy Services, identified in Benzer’s civil agreement as a Benzer affiliate, pleaded guilty to health care fraud on May 13, 2025. The Justice Department’s announcement of the plea identifies the Florida pharmacy as also known as Benzer and Auburndale.

In announcing the guilty plea, the Justice Department said OHM admitted that it dispensed Evzio, completed authorization forms in physicians’ place and sometimes signed without their permission. It submitted information that made the request appear to come from a physician. OHM also admitted submitting false treatment histories, including statements that patients had tried and failed to use Narcan or naloxone successfully.

Across the civil agreement and the account of OHM’s plea, the operational point is consistent: pharmacy personnel controlled information that insurers expected to receive from the prescribing office. The case reaches the work behind the form, including who prepared it and how it reached the payer.

The Same Evzio Practice at Another Pharmacy

The Justice Department’s July 2022 account of Solera Specialty Pharmacy described admissions about a similar Evzio authorization process. Staff completed forms in physicians’ place, sometimes signed without permission, substituted pharmacy contact details and submitted false clinical information. Solera entered a deferred prosecution agreement and a civil settlement.

That parallel matters because the mechanism ran through ordinary authorization work. A signature, a contact field and a clinical answer could make a pharmacy’s submission look like a physician’s.

The manufacturer had a separate role. In the Kaleo manufacturer case, the government alleged that Kaleo directed prescriptions to preferred pharmacies, including Benzer. That allegation concerns how prescriptions reached the pharmacy. Benzer’s admissions concern what the pharmacy then told insurers to obtain payment. An insider may know either side of that handoff.

The Records Behind the Approved Claim

The useful connection runs from the physician’s order and clinical information through the authorization request to the payer’s decision and the pharmacy’s payment. Each record answers a different part of the case: what was prescribed, what was represented, who supplied the answer and what the insurer approved.

In the pharmacy business, the order, billing transaction and remittance travel along different paths. The prescriber supplies the prescription and its changes. The pharmacy sends billing, reversal and rebill transactions to a processor. The payment record shows the reimbursement and later adjustments. The dispensing and reversal records connect that billing history to what happened to the prescription.

For Benzer’s authorization practices, we focus on the original form, the actual prescriber approval, the contact information used and the clinical support for the answers. The payment history then connects the request to the claim it helped get approved. A reimbursement employee may see the approval and payment. An authorization employee may know how the answers were written. Their knowledge can meet at the same prescription.

Someone outside the pharmacy may understand how prescriptions arrived there, while someone inside knows how the authorization was completed. We work with the part you know and build the connections around it.

The Civil Settlement and Whistleblower Share

Benzer’s civil agreement provides a 28% whistleblower share of the government’s recovery. A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers. For an authorization or reimbursement insider, the starting point is the work you understand: who supplied the answers, how they reached the insurer and which prescriptions the insurer paid for.

When the Answers Came From Inside the Pharmacy

If you handled authorization requests or reimbursement and know who supplied the clinical answers, talk with our whistleblower experts about what happened inside the pharmacy. We build your strongest pharmacy fraud whistleblower case around the decisions behind those requests and bring in pharmacy fraud whistleblower lawyers who understand prescriber authorizations and government healthcare billing. We stay beside you as partners through the case, starting with the part of the process you know firsthand.

WHISTLEBLOWER JUSTICE NETWORK CAN HELP YOU
Make a difference.
Whistleblower Justice NetworkReport Fraud
100% CONFIDENTIALFREE CONSULTATION24 / 7 / 365